GSDMD is a novel predictive biomarker for immunotherapy response: in the pan-cancer and single cell landscapes
{{output}}
Background: Gasdermin D (GSDMD), a key executor of pyroptosis, has been implicated in modulating the tumor immune microenvironment. However, its role as a predictive biomarker for immunotherapy response remains unclear. ... ...
